Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Vorinostat to Restore Sensitivity to Aromatase Inhibitor Therapy

NCT01153672 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT01153672
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01153672 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Vorinostat to Restore Sensitivity to Aromatase Inhibitor Therapy
Lead sponsor
University of Washington
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2010
Completion date
August 11, 2016
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

male breast cancer, recurrent breast cancer, stage iv breast cancer